SCHEMBL19970812

SCHEMBL19970812

CCOP(=O)(Cc1cccc(COc2ccccc2C=O)c1)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SRC P12931 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CCNT1 O60563 3/20 0.43
CDK9 P50750 3/20 0.43
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA1D P25100 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19970788 0.89 KMT2A (0.48) KMT2ATDP1L3MBTL1SRCALDH1A1
SCHEMBL23843054 0.82 MRGPRX4 (0.46) ALDH1A1SMN1; SMN2CCNT1CDK9MRGPRX4
SCHEMBL19986739 0.81 MRGPRX4 (0.44) ALDH1A1SMN1; SMN2CCNT1CDK9MRGPRX4
SCHEMBL3390402 0.78 CCNT1 (0.46) HTTCCNT1CDK9
SCHEMBL19982648 0.77 KMT2A (0.49) KMT2ATDP1L3MBTL1ALDH1A1HPGD
SCHEMBL19986741 0.77 KMT2A (0.49) KMT2ATDP1L3MBTL1ALDH1A1HPGD
SCHEMBL30722248 0.76 MAOB (0.57) KMT2ATDP1L3MBTL1ALDH1A1HPGD
SCHEMBL21332156 0.76 MAOB (0.57) KMT2ATDP1L3MBTL1ALDH1A1HPGD
SCHEMBL9155887 0.74 MAOA (0.42) TDP1SRCALDH1A1CCNT1CDK9
SCHEMBL23843006 0.74 HTR6 (0.48) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-10-25 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
EP-3512838-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION Centre National De La Recherche Scientifique (FR) 2019-07-24 EP disclosed
WO-2018050771-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-22 WO disclosed
WO-2018050771-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-22 WO disclosed
EP-3296297-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION FIP1L1, ZC3HAV1, MAVS KMT2A 3401/4885TDP1 1281/4885L3MBTL1 495/4885
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection FIP1L1, ZC3HAV1, MAVS KMT2A 3401/4885TDP1 1281/4885L3MBTL1 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.